Skip to main content
Top
Published in: Virology Journal 1/2013

Open Access 01-12-2013 | Research

Examination of soluble integrin resistant mutants of foot-and-mouth disease virus

Authors: Paul Lawrence, Michael LaRocco, Barry Baxt, Elizabeth Rieder

Published in: Virology Journal | Issue 1/2013

Login to get access

Abstract

Background

Foot-and-mouth disease virus (FMDV) initiates infection via recognition of one of at least four cell-surface integrin molecules αvβ1, αvβ3, αvβ6, or αvβ8 by a highly conserved Arg-Gly-Asp (RGD) amino acid sequence motif located in the G-H loop of VP1. Within the animal host, the αvβ6 interaction is believed to be the most relevant. Sub-neutralizing levels of soluble secreted αvβ6 (ssαvβ6) was used as a selective pressure during passages in vitro to explore the plasticity of that interaction.

Results

Genetically stable soluble integrin resistant (SIR) FMDV mutants derived from A24 Cruzeiro were selected after just 3 passages in cell culture in the presence of sub-neutralizing levels of ssαvβ6. SIR mutants were characterized by: replication on selective cell lines, plaque morphology, relative sensitivity to ssαvβ6 neutralization, relative ability to utilize αvβ6 for infection, as well as sequence and structural changes. All SIR mutants maintained an affinity for αvβ6. Some developed the ability to attach to cells expressing heparan sulfate (HS) proteoglycan, while others appear to have developed affinity for a still unknown third receptor. Two classes of SIR mutants were selected that were highly or moderately resistant to neutralization by ssαvβ6. Highly resistant mutants displayed a G145D substitution (RGD to RDD), while moderately resistant viruses exhibited a L150P/R substitution at the conserved RGD + 4 position. VP1 G-H loop homology models for the A-type SIR mutants illustrated potential structural changes within the integrin-binding motif by these 2 groups of mutations. Treatment of O1 Campos with ssαvβ6 resulted in 3 SIR mutants with a positively charged VP3 mutation allowing for HS binding.

Conclusions

These findings illustrate how FMDV particles rapidly gain resistance to soluble receptor prophylactic measures in vitro. Two different serotypes developed distinct capsid mutations to circumvent the presence of sub-neutralizing levels of the soluble cognate receptor, all of which resulted in a modified receptor tropism that expanded the cell types susceptible to FMDV. The identification of some of these adaptive mutations in known FMDV isolates suggests these findings have implications beyond the cell culture system explored in these studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Domingo E, Baranowski E, Escarmis C, Sobrino F: Foot-and-mouth disease virus. Comp Immunol Microbiol Infect Dis 2002, 25: 297-308. 10.1016/S0147-9571(02)00027-9PubMedCrossRef Domingo E, Baranowski E, Escarmis C, Sobrino F: Foot-and-mouth disease virus. Comp Immunol Microbiol Infect Dis 2002, 25: 297-308. 10.1016/S0147-9571(02)00027-9PubMedCrossRef
3.
go back to reference Mason PW, Grubman MJ, Baxt B: Molecular basis of pathogenesis of FMDV. Virus Res 2003, 91: 9-32. 10.1016/S0168-1702(02)00257-5PubMedCrossRef Mason PW, Grubman MJ, Baxt B: Molecular basis of pathogenesis of FMDV. Virus Res 2003, 91: 9-32. 10.1016/S0168-1702(02)00257-5PubMedCrossRef
4.
go back to reference Saiz M, Nunez JI, Jimenez-Clavero MA, Baranowski E, Sobrino F: Foot-and-mouth disease virus: biology and prospects for disease control. Microbes Infect 2002, 4: 1183-1192. 10.1016/S1286-4579(02)01644-1PubMedCrossRef Saiz M, Nunez JI, Jimenez-Clavero MA, Baranowski E, Sobrino F: Foot-and-mouth disease virus: biology and prospects for disease control. Microbes Infect 2002, 4: 1183-1192. 10.1016/S1286-4579(02)01644-1PubMedCrossRef
5.
go back to reference Sobrino F, Saiz M, Jimenez-Clavero MA, Nunez JI, Rosas MF, Baranowski E, Ley V: Foot-and-mouth disease virus: a long known virus, but a current threat. Vet Res 2001, 32: 1-30. 10.1051/vetres:2001106PubMedCrossRef Sobrino F, Saiz M, Jimenez-Clavero MA, Nunez JI, Rosas MF, Baranowski E, Ley V: Foot-and-mouth disease virus: a long known virus, but a current threat. Vet Res 2001, 32: 1-30. 10.1051/vetres:2001106PubMedCrossRef
6.
go back to reference Baxt B, Becker Y: The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells. Virus Genes 1990, 4: 73-83. 10.1007/BF00308567PubMedCrossRef Baxt B, Becker Y: The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells. Virus Genes 1990, 4: 73-83. 10.1007/BF00308567PubMedCrossRef
7.
go back to reference Duque H, Baxt B: Foot-and-mouth disease virus receptors: comparison of bovine alpha(V) integrin utilization by type A and O viruses. J Virol 2003, 77: 2500-2511. 10.1128/JVI.77.4.2500-2511.2003PubMedPubMedCentralCrossRef Duque H, Baxt B: Foot-and-mouth disease virus receptors: comparison of bovine alpha(V) integrin utilization by type A and O viruses. J Virol 2003, 77: 2500-2511. 10.1128/JVI.77.4.2500-2511.2003PubMedPubMedCentralCrossRef
8.
go back to reference Jackson T, Blakemore W, Newman JW, Knowles NJ, Mould AP, Humphries MJ, King AM: Foot-and-mouth disease virus is a ligand for the high-affinity binding conformation of integrin alpha5beta1: influence of the leucine residue within the RGDL motif on selectivity of integrin binding. J Gen Virol 2000, 81: 1383-1391.PubMedCrossRef Jackson T, Blakemore W, Newman JW, Knowles NJ, Mould AP, Humphries MJ, King AM: Foot-and-mouth disease virus is a ligand for the high-affinity binding conformation of integrin alpha5beta1: influence of the leucine residue within the RGDL motif on selectivity of integrin binding. J Gen Virol 2000, 81: 1383-1391.PubMedCrossRef
9.
go back to reference Jackson T, Clark S, Berryman S, Burman A, Cambier S, Mu D, Nishimura S, King AM: Integrin alphavbeta8 functions as a receptor for foot-and-mouth disease virus: role of the beta-chain cytodomain in integrin-mediated infection. J Virol 2004, 78: 4533-4540. 10.1128/JVI.78.9.4533-4540.2004PubMedPubMedCentralCrossRef Jackson T, Clark S, Berryman S, Burman A, Cambier S, Mu D, Nishimura S, King AM: Integrin alphavbeta8 functions as a receptor for foot-and-mouth disease virus: role of the beta-chain cytodomain in integrin-mediated infection. J Virol 2004, 78: 4533-4540. 10.1128/JVI.78.9.4533-4540.2004PubMedPubMedCentralCrossRef
10.
go back to reference Jackson T, Mould AP, Sheppard D, King AM: Integrin alphavbeta1 is a receptor for foot-and-mouth disease virus. J Virol 2002, 76: 935-941. 10.1128/JVI.76.3.935-941.2002PubMedPubMedCentralCrossRef Jackson T, Mould AP, Sheppard D, King AM: Integrin alphavbeta1 is a receptor for foot-and-mouth disease virus. J Virol 2002, 76: 935-941. 10.1128/JVI.76.3.935-941.2002PubMedPubMedCentralCrossRef
11.
go back to reference Jackson T, Sheppard D, Denyer M, Blakemore W, King AM: The epithelial integrin alphavbeta6 is a receptor for foot-and-mouth disease virus. J Virol 2000, 74: 4949-4956. 10.1128/JVI.74.11.4949-4956.2000PubMedPubMedCentralCrossRef Jackson T, Sheppard D, Denyer M, Blakemore W, King AM: The epithelial integrin alphavbeta6 is a receptor for foot-and-mouth disease virus. J Virol 2000, 74: 4949-4956. 10.1128/JVI.74.11.4949-4956.2000PubMedPubMedCentralCrossRef
12.
go back to reference Neff S, Sa-Carvalho D, Rieder E, Mason PW, Blystone SD, Brown EJ, Baxt B: Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor. J Virol 1998, 72: 3587-3594.PubMedPubMedCentral Neff S, Sa-Carvalho D, Rieder E, Mason PW, Blystone SD, Brown EJ, Baxt B: Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor. J Virol 1998, 72: 3587-3594.PubMedPubMedCentral
13.
go back to reference O'Donnell V, LaRocco M, Duque H, Baxt B: Analysis of foot-and-mouth disease virus internalization events in cultured cells. J Virol 2005, 79: 8506-8518. 10.1128/JVI.79.13.8506-8518.2005PubMedPubMedCentralCrossRef O'Donnell V, LaRocco M, Duque H, Baxt B: Analysis of foot-and-mouth disease virus internalization events in cultured cells. J Virol 2005, 79: 8506-8518. 10.1128/JVI.79.13.8506-8518.2005PubMedPubMedCentralCrossRef
14.
go back to reference Ruiz-Saenz J, Goez Y, Tabares W, Lopez-Herrera A: Cellular receptors for foot and mouth disease virus. Intervirology 2009, 52: 201-212. 10.1159/000226121PubMedCrossRef Ruiz-Saenz J, Goez Y, Tabares W, Lopez-Herrera A: Cellular receptors for foot and mouth disease virus. Intervirology 2009, 52: 201-212. 10.1159/000226121PubMedCrossRef
15.
go back to reference Brown F, Benkirane N, Limal D, Halimi H, Newman JF, Van Regenmortel MH, Briand JP, Muller S: Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif. Vaccine 1999, 18: 50-56. 10.1016/S0264-410X(99)00169-3PubMedCrossRef Brown F, Benkirane N, Limal D, Halimi H, Newman JF, Van Regenmortel MH, Briand JP, Muller S: Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif. Vaccine 1999, 18: 50-56. 10.1016/S0264-410X(99)00169-3PubMedCrossRef
16.
go back to reference Burman A, Clark S, Abrescia NG, Fry EE, Stuart DI, Jackson T: Specificity of the VP1 GH loop of Foot-and-Mouth Disease virus for alphav integrins. J Virol 2006, 80: 9798-9810. 10.1128/JVI.00577-06PubMedPubMedCentralCrossRef Burman A, Clark S, Abrescia NG, Fry EE, Stuart DI, Jackson T: Specificity of the VP1 GH loop of Foot-and-Mouth Disease virus for alphav integrins. J Virol 2006, 80: 9798-9810. 10.1128/JVI.00577-06PubMedPubMedCentralCrossRef
17.
go back to reference Fox G, Parry NR, Barnett PV, McGinn B, Rowlands DJ, Brown F: The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J Gen Virol 1989,70(Pt 3):625-637.PubMedCrossRef Fox G, Parry NR, Barnett PV, McGinn B, Rowlands DJ, Brown F: The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J Gen Virol 1989,70(Pt 3):625-637.PubMedCrossRef
18.
go back to reference Robertson BH, Morgan DO, Moore DM: Location of neutralizing epitopes defined by monoclonal antibodies generated against the outer capsid polypeptide, VP1, of foot-and-mouth disease virus A12. Virus Res 1984, 1: 489-500. 10.1016/0168-1702(84)90006-6PubMedCrossRef Robertson BH, Morgan DO, Moore DM: Location of neutralizing epitopes defined by monoclonal antibodies generated against the outer capsid polypeptide, VP1, of foot-and-mouth disease virus A12. Virus Res 1984, 1: 489-500. 10.1016/0168-1702(84)90006-6PubMedCrossRef
19.
go back to reference Strohmaier K, Franze R, Adam KH: Location and characterization of the antigenic portion of the FMDV immunizing protein. J Gen Virol 1982, 59: 295-306. 10.1099/0022-1317-59-2-295PubMedCrossRef Strohmaier K, Franze R, Adam KH: Location and characterization of the antigenic portion of the FMDV immunizing protein. J Gen Virol 1982, 59: 295-306. 10.1099/0022-1317-59-2-295PubMedCrossRef
20.
go back to reference Wild TF, Brown F: Nature of the inactivating action of trypsin on foot-and-mouth disease virus. J Gen Virol 1967, 1: 247-250. 10.1099/0022-1317-1-2-247PubMedCrossRef Wild TF, Brown F: Nature of the inactivating action of trypsin on foot-and-mouth disease virus. J Gen Virol 1967, 1: 247-250. 10.1099/0022-1317-1-2-247PubMedCrossRef
21.
go back to reference Baranowski E, Ruiz-Jarabo CM, Sevilla N, Andreu D, Beck E, Domingo E: Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage. J Virol 2000, 74: 1641-1647. 10.1128/JVI.74.4.1641-1647.2000PubMedPubMedCentralCrossRef Baranowski E, Ruiz-Jarabo CM, Sevilla N, Andreu D, Beck E, Domingo E: Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage. J Virol 2000, 74: 1641-1647. 10.1128/JVI.74.4.1641-1647.2000PubMedPubMedCentralCrossRef
22.
go back to reference Fry EE, Lea SM, Jackson T, Newman JW, Ellard FM, Blakemore WE, Abu-Ghazaleh R, Samuel A, King AM, Stuart DI: The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J 1999, 18: 543-554. 10.1093/emboj/18.3.543PubMedPubMedCentralCrossRef Fry EE, Lea SM, Jackson T, Newman JW, Ellard FM, Blakemore WE, Abu-Ghazaleh R, Samuel A, King AM, Stuart DI: The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J 1999, 18: 543-554. 10.1093/emboj/18.3.543PubMedPubMedCentralCrossRef
23.
go back to reference Jackson T, Ellard FM, Ghazaleh RA, Brookes SM, Blakemore WE, Corteyn AH, Stuart DI, Newman JW, King AM: Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J Virol 1996, 70: 5282-5287.PubMedPubMedCentral Jackson T, Ellard FM, Ghazaleh RA, Brookes SM, Blakemore WE, Corteyn AH, Stuart DI, Newman JW, King AM: Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J Virol 1996, 70: 5282-5287.PubMedPubMedCentral
24.
go back to reference Sa-Carvalho D, Rieder E, Baxt B, Rodarte R, Tanuri A, Mason PW: Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J Virol 1997, 71: 5115-5123.PubMedPubMedCentral Sa-Carvalho D, Rieder E, Baxt B, Rodarte R, Tanuri A, Mason PW: Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J Virol 1997, 71: 5115-5123.PubMedPubMedCentral
25.
go back to reference Duque H, LaRocco M, Golde WT, Baxt B: Interactions of foot-and-mouth disease virus with soluble bovine alphaVbeta3 and alphaVbeta6 integrins. J Virol 2004, 78: 9773-9781. 10.1128/JVI.78.18.9773-9781.2004PubMedPubMedCentralCrossRef Duque H, LaRocco M, Golde WT, Baxt B: Interactions of foot-and-mouth disease virus with soluble bovine alphaVbeta3 and alphaVbeta6 integrins. J Virol 2004, 78: 9773-9781. 10.1128/JVI.78.18.9773-9781.2004PubMedPubMedCentralCrossRef
26.
go back to reference Colston E, Racaniello VR: Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor. EMBO J 1994, 13: 5855-5862.PubMedPubMedCentral Colston E, Racaniello VR: Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor. EMBO J 1994, 13: 5855-5862.PubMedPubMedCentral
27.
go back to reference Colston EM, Racaniello VR: Poliovirus variants selected on mutant receptor-expressing cells identify capsid residues that expand receptor recognition. J Virol 1995, 69: 4823-4829.PubMedPubMedCentral Colston EM, Racaniello VR: Poliovirus variants selected on mutant receptor-expressing cells identify capsid residues that expand receptor recognition. J Virol 1995, 69: 4823-4829.PubMedPubMedCentral
28.
go back to reference Monaghan P, Gold S, Simpson J, Zhang Z, Weinreb PH, Violette SM, Alexandersen S, Jackson T: The alpha(v)beta6 integrin receptor for Foot-and-mouth disease virus is expressed constitutively on the epithelial cells targeted in cattle. J Gen Virol 2005, 86: 2769-2780. 10.1099/vir.0.81172-0PubMedCrossRef Monaghan P, Gold S, Simpson J, Zhang Z, Weinreb PH, Violette SM, Alexandersen S, Jackson T: The alpha(v)beta6 integrin receptor for Foot-and-mouth disease virus is expressed constitutively on the epithelial cells targeted in cattle. J Gen Virol 2005, 86: 2769-2780. 10.1099/vir.0.81172-0PubMedCrossRef
29.
go back to reference Swaney LM: A continuous bovine kidney cell line for routine assays of foot-and-mouth disease virus. Vet Microbiol 1988, 18: 1-14. 10.1016/0378-1135(88)90111-3PubMedCrossRef Swaney LM: A continuous bovine kidney cell line for routine assays of foot-and-mouth disease virus. Vet Microbiol 1988, 18: 1-14. 10.1016/0378-1135(88)90111-3PubMedCrossRef
30.
go back to reference Weinacker A, Chen A, Agrez M, Cone RI, Nishimura S, Wayner E, Pytela R, Sheppard D: Role of the integrin alpha v beta 6 in cell attachment to fibronectin. Heterologous expression of intact and secreted forms of the receptor. J Biol Chem 1994, 269: 6940-6948.PubMed Weinacker A, Chen A, Agrez M, Cone RI, Nishimura S, Wayner E, Pytela R, Sheppard D: Role of the integrin alpha v beta 6 in cell attachment to fibronectin. Heterologous expression of intact and secreted forms of the receptor. J Biol Chem 1994, 269: 6940-6948.PubMed
31.
go back to reference Gianni T, Cerretani A, Dubois R, Salvioli S, Blystone SS, Rey F, Campadelli-Fiume G: Herpes simplex virus glycoproteins H/L bind to cells independently of {alpha}V{beta}3 integrin and inhibit virus entry, and their constitutive expression restricts infection. J Virol 2010, 84: 4013-4025. 10.1128/JVI.02502-09PubMedPubMedCentralCrossRef Gianni T, Cerretani A, Dubois R, Salvioli S, Blystone SS, Rey F, Campadelli-Fiume G: Herpes simplex virus glycoproteins H/L bind to cells independently of {alpha}V{beta}3 integrin and inhibit virus entry, and their constitutive expression restricts infection. J Virol 2010, 84: 4013-4025. 10.1128/JVI.02502-09PubMedPubMedCentralCrossRef
32.
go back to reference Gianni T, Gatta V, Campadelli-Fiume G: {alpha}V{beta}3-integrin routes herpes simplex virus to an entry pathway dependent on cholesterol-rich lipid rafts and dynamin2. Proc Natl Acad Sci USA 2010, 107: 22260-22265. 10.1073/pnas.1014923108PubMedPubMedCentralCrossRef Gianni T, Gatta V, Campadelli-Fiume G: {alpha}V{beta}3-integrin routes herpes simplex virus to an entry pathway dependent on cholesterol-rich lipid rafts and dynamin2. Proc Natl Acad Sci USA 2010, 107: 22260-22265. 10.1073/pnas.1014923108PubMedPubMedCentralCrossRef
33.
go back to reference Xu X, Nagarajan H, Lewis NE, Pan S, Cai Z, Liu X, Chen W, Xie M, Wang W, Hammond S, Andersen MR, Neff N, Passarelli B, Koh W, Fan HC, Wang J, Gui Y, Lee KH, Betenbaugh MJ, Quake SR, Famili I, Palsson BO, Wang J: The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nat Biotechnol 2011, 29: 735-741. 10.1038/nbt.1932PubMedPubMedCentralCrossRef Xu X, Nagarajan H, Lewis NE, Pan S, Cai Z, Liu X, Chen W, Xie M, Wang W, Hammond S, Andersen MR, Neff N, Passarelli B, Koh W, Fan HC, Wang J, Gui Y, Lee KH, Betenbaugh MJ, Quake SR, Famili I, Palsson BO, Wang J: The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nat Biotechnol 2011, 29: 735-741. 10.1038/nbt.1932PubMedPubMedCentralCrossRef
34.
go back to reference Esko JD, Stewart TE, Taylor WH: Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc Natl Acad Sci USA 1985, 82: 3197-3201. 10.1073/pnas.82.10.3197PubMedPubMedCentralCrossRef Esko JD, Stewart TE, Taylor WH: Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc Natl Acad Sci USA 1985, 82: 3197-3201. 10.1073/pnas.82.10.3197PubMedPubMedCentralCrossRef
35.
go back to reference Esko JD, Weinke JL, Taylor WH, Ekborg G, Roden L, Anantharamaiah G, Gawish A: Inhibition of chondroitin and heparan sulfate biosynthesis in Chinese hamster ovary cell mutants defective in galactosyltransferase I. J Biol Chem 1987, 262: 12189-12195.PubMed Esko JD, Weinke JL, Taylor WH, Ekborg G, Roden L, Anantharamaiah G, Gawish A: Inhibition of chondroitin and heparan sulfate biosynthesis in Chinese hamster ovary cell mutants defective in galactosyltransferase I. J Biol Chem 1987, 262: 12189-12195.PubMed
36.
go back to reference Maree FF, Blignaut B, Aschenbrenner L, Burrage T, Rieder E: Analysis of SAT1 type foot-and-mouth disease virus capsid proteins: influence of receptor usage on the properties of virus particles. Virus Res 2011, 155: 462-472. 10.1016/j.virusres.2010.12.002PubMedCrossRef Maree FF, Blignaut B, Aschenbrenner L, Burrage T, Rieder E: Analysis of SAT1 type foot-and-mouth disease virus capsid proteins: influence of receptor usage on the properties of virus particles. Virus Res 2011, 155: 462-472. 10.1016/j.virusres.2010.12.002PubMedCrossRef
37.
go back to reference Maree FF, Blignaut B, de Beer TA, Visser N, Rieder EA: Mapping of amino acid residues responsible for adhesion of cell culture-adapted foot-and-mouth disease SAT type viruses. Virus Res 2010, 153: 82-91. 10.1016/j.virusres.2010.07.010PubMedCrossRef Maree FF, Blignaut B, de Beer TA, Visser N, Rieder EA: Mapping of amino acid residues responsible for adhesion of cell culture-adapted foot-and-mouth disease SAT type viruses. Virus Res 2010, 153: 82-91. 10.1016/j.virusres.2010.07.010PubMedCrossRef
38.
go back to reference Lidholt K, Weinke JL, Kiser CS, Lugemwa FN, Bame KJ, Cheifetz S, Massague J, Lindahl U, Esko JD: A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis. Proc Natl Acad Sci USA 1992, 89: 2267-2271. 10.1073/pnas.89.6.2267PubMedPubMedCentralCrossRef Lidholt K, Weinke JL, Kiser CS, Lugemwa FN, Bame KJ, Cheifetz S, Massague J, Lindahl U, Esko JD: A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis. Proc Natl Acad Sci USA 1992, 89: 2267-2271. 10.1073/pnas.89.6.2267PubMedPubMedCentralCrossRef
39.
go back to reference Esko JD, Rostand KS, Weinke JL: Tumor formation dependent on proteoglycan biosynthesis. Science 1988, 241: 1092-1096. 10.1126/science.3137658PubMedCrossRef Esko JD, Rostand KS, Weinke JL: Tumor formation dependent on proteoglycan biosynthesis. Science 1988, 241: 1092-1096. 10.1126/science.3137658PubMedCrossRef
40.
go back to reference Stephens RS, Poteralski JM, Olinger L: Interaction of Chlamydia trachomatis with mammalian cells is independent of host cell surface heparan sulfate glycosaminoglycans. Infect Immun 2006, 74: 1795-1799. 10.1128/IAI.74.3.1795-1799.2006PubMedPubMedCentralCrossRef Stephens RS, Poteralski JM, Olinger L: Interaction of Chlamydia trachomatis with mammalian cells is independent of host cell surface heparan sulfate glycosaminoglycans. Infect Immun 2006, 74: 1795-1799. 10.1128/IAI.74.3.1795-1799.2006PubMedPubMedCentralCrossRef
41.
go back to reference Zhao QZ, Pacheco JM, Mason PW: Evaluation of genetically engineered derivatives of a Chinese strain of foot-and-mouth disease virus reveals a novel cell-binding site which functions in cell culture and in animals. J Virol 2003, 77: 3269-3280. 10.1128/JVI.77.5.3269-3280.2003PubMedPubMedCentralCrossRef Zhao QZ, Pacheco JM, Mason PW: Evaluation of genetically engineered derivatives of a Chinese strain of foot-and-mouth disease virus reveals a novel cell-binding site which functions in cell culture and in animals. J Virol 2003, 77: 3269-3280. 10.1128/JVI.77.5.3269-3280.2003PubMedPubMedCentralCrossRef
42.
go back to reference Johns HL, Berryman S, Monaghan P, Belsham GJ, Jackson T: A dominant-negative mutant of rab5 inhibits infection of cells by foot-and-mouth disease virus: implications for virus entry. J Virol 2009, 83: 6247-6256. 10.1128/JVI.02460-08PubMedPubMedCentralCrossRef Johns HL, Berryman S, Monaghan P, Belsham GJ, Jackson T: A dominant-negative mutant of rab5 inhibits infection of cells by foot-and-mouth disease virus: implications for virus entry. J Virol 2009, 83: 6247-6256. 10.1128/JVI.02460-08PubMedPubMedCentralCrossRef
43.
go back to reference O'Donnell V, Larocco M, Baxt B: Heparan sulfate-binding foot-and-mouth disease virus enters cells via caveola-mediated endocytosis. J Virol 2008, 82: 9075-9085. 10.1128/JVI.00732-08PubMedPubMedCentralCrossRef O'Donnell V, Larocco M, Baxt B: Heparan sulfate-binding foot-and-mouth disease virus enters cells via caveola-mediated endocytosis. J Virol 2008, 82: 9075-9085. 10.1128/JVI.00732-08PubMedPubMedCentralCrossRef
44.
go back to reference O'Donnell CD, Shukla D: A novel function of heparan sulfate in the regulation of cell-cell fusion. J Biol Chem 2009, 284: 29654-29665. 10.1074/jbc.M109.037960PubMedPubMedCentralCrossRef O'Donnell CD, Shukla D: A novel function of heparan sulfate in the regulation of cell-cell fusion. J Biol Chem 2009, 284: 29654-29665. 10.1074/jbc.M109.037960PubMedPubMedCentralCrossRef
45.
go back to reference Neff S, Mason PW, Baxt B: High-efficiency utilization of the bovine integrin alpha(v) beta(3) as a receptor for foot-and-mouth disease virus is dependent on the bovine beta(3) subunit. J Virol 2000, 74: 7298-7306. 10.1128/JVI.74.16.7298-7306.2000PubMedPubMedCentralCrossRef Neff S, Mason PW, Baxt B: High-efficiency utilization of the bovine integrin alpha(v) beta(3) as a receptor for foot-and-mouth disease virus is dependent on the bovine beta(3) subunit. J Virol 2000, 74: 7298-7306. 10.1128/JVI.74.16.7298-7306.2000PubMedPubMedCentralCrossRef
46.
go back to reference Dicara D, Burman A, Clark S, Berryman S, Howard MJ, Hart IR, Marshall JF, Jackson T: Foot-and-mouth disease virus forms a highly stable, EDTA-resistant complex with its principal receptor, integrin alphavbeta6: implications for infectiousness. J Virol 2008, 82: 1537-1546. 10.1128/JVI.01480-07PubMedPubMedCentralCrossRef Dicara D, Burman A, Clark S, Berryman S, Howard MJ, Hart IR, Marshall JF, Jackson T: Foot-and-mouth disease virus forms a highly stable, EDTA-resistant complex with its principal receptor, integrin alphavbeta6: implications for infectiousness. J Virol 2008, 82: 1537-1546. 10.1128/JVI.01480-07PubMedPubMedCentralCrossRef
47.
go back to reference Domingo E, Escarmis C, Martinez MA, Martinez-Salas E, Mateu MG: Foot-and-mouth disease virus populations are quasispecies. Curr Top Microbiol Immunol 1992, 176: 33-47. 10.1007/978-3-642-77011-1_3PubMed Domingo E, Escarmis C, Martinez MA, Martinez-Salas E, Mateu MG: Foot-and-mouth disease virus populations are quasispecies. Curr Top Microbiol Immunol 1992, 176: 33-47. 10.1007/978-3-642-77011-1_3PubMed
48.
go back to reference Mateu MG, Valero ML, Andreu D, Domingo E: Systematic replacement of amino acid residues within an Arg-Gly-Asp-containing loop of foot-and-mouth disease virus and effect on cell recognition. J Biol Chem 1996, 271: 12814-12819. 10.1074/jbc.271.22.12814PubMedCrossRef Mateu MG, Valero ML, Andreu D, Domingo E: Systematic replacement of amino acid residues within an Arg-Gly-Asp-containing loop of foot-and-mouth disease virus and effect on cell recognition. J Biol Chem 1996, 271: 12814-12819. 10.1074/jbc.271.22.12814PubMedCrossRef
49.
go back to reference Rieder E, Baxt B, Mason PW: Animal-derived antigenic variants of foot-and-mouth disease virus type A12 have low affinity for cells in culture. J Virol 1994, 68: 5296-5299.PubMedPubMedCentral Rieder E, Baxt B, Mason PW: Animal-derived antigenic variants of foot-and-mouth disease virus type A12 have low affinity for cells in culture. J Virol 1994, 68: 5296-5299.PubMedPubMedCentral
50.
go back to reference Nunez JI, Martin MJ, Piccone ME, Carrillo E, Palma EL, Dopazo J, Sobrino F: Identification of optimal regions for phylogenetic studies on VP1 gene of foot-and-mouth disease virus: analysis of types A and O Argentinean viruses. Vet Res 2001, 32: 31-45. 10.1051/vetres:2001107PubMedCrossRef Nunez JI, Martin MJ, Piccone ME, Carrillo E, Palma EL, Dopazo J, Sobrino F: Identification of optimal regions for phylogenetic studies on VP1 gene of foot-and-mouth disease virus: analysis of types A and O Argentinean viruses. Vet Res 2001, 32: 31-45. 10.1051/vetres:2001107PubMedCrossRef
51.
go back to reference Weddell GN, Yansura DG, Dowbenko DJ, Hoatlin ME, Grubman MJ, Moore DM, Kleid DG: Sequence variation in the gene for the immunogenic capsid protein VP1 of foot-and-mouth disease virus type A. Proc Natl Acad Sci USA 1985, 82: 2618-2622. 10.1073/pnas.82.9.2618PubMedPubMedCentralCrossRef Weddell GN, Yansura DG, Dowbenko DJ, Hoatlin ME, Grubman MJ, Moore DM, Kleid DG: Sequence variation in the gene for the immunogenic capsid protein VP1 of foot-and-mouth disease virus type A. Proc Natl Acad Sci USA 1985, 82: 2618-2622. 10.1073/pnas.82.9.2618PubMedPubMedCentralCrossRef
52.
go back to reference Logan D, Abu-Ghazaleh R, Blakemore W, Curry S, Jackson T, King A, Lea S, Lewis R, Newman J, Parry N, et al.: Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 1993, 362: 566-568. 10.1038/362566a0PubMedCrossRef Logan D, Abu-Ghazaleh R, Blakemore W, Curry S, Jackson T, King A, Lea S, Lewis R, Newman J, Parry N, et al.: Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 1993, 362: 566-568. 10.1038/362566a0PubMedCrossRef
53.
go back to reference Combet C, Jambon M, Deleage G, Geourjon C: Geno3D: automatic comparative molecular modelling of protein. Bioinformatics 2002, 18: 213-214. 10.1093/bioinformatics/18.1.213PubMedCrossRef Combet C, Jambon M, Deleage G, Geourjon C: Geno3D: automatic comparative molecular modelling of protein. Bioinformatics 2002, 18: 213-214. 10.1093/bioinformatics/18.1.213PubMedCrossRef
54.
go back to reference Borca MV, Pacheco JM, Holinka LG, Carrillo C, Hartwig E, Garriga D, Kramer E, Rodriguez L, Piccone ME: Role of arginine-56 within the structural protein VP3 of foot-and-mouth disease virus (FMDV) O1 Campos in virus virulence. Virology 2011, 422: 37-45.PubMedCrossRef Borca MV, Pacheco JM, Holinka LG, Carrillo C, Hartwig E, Garriga D, Kramer E, Rodriguez L, Piccone ME: Role of arginine-56 within the structural protein VP3 of foot-and-mouth disease virus (FMDV) O1 Campos in virus virulence. Virology 2011, 422: 37-45.PubMedCrossRef
55.
go back to reference Ojosnegros S, Perales C, Mas A, Domingo E: Quasispecies as a matter of fact: Viruses and beyond. Virus Res 2011. In press Ojosnegros S, Perales C, Mas A, Domingo E: Quasispecies as a matter of fact: Viruses and beyond. Virus Res 2011. In press
56.
go back to reference Wells VR, Plotch SJ, DeStefano JJ: Determination of the mutation rate of poliovirus RNA-dependent RNA polymerase. Virus Res 2001, 74: 119-132. 10.1016/S0168-1702(00)00256-2PubMedCrossRef Wells VR, Plotch SJ, DeStefano JJ: Determination of the mutation rate of poliovirus RNA-dependent RNA polymerase. Virus Res 2001, 74: 119-132. 10.1016/S0168-1702(00)00256-2PubMedCrossRef
57.
go back to reference Li P, Lu Z, Bao H, Li D, King DP, Sun P, Bai X, Cao W, Gubbins S, Chen Y, Xie B, Guo J, Yin H, Liu Z: In-vitro and in-vivo phenotype of Asia1 foot-and-mouth disease viruses utilizing two non-RGD receptor recognition sites. BMC Microbiol 2011, 11: 1-12. 10.1186/1471-2180-11-1CrossRef Li P, Lu Z, Bao H, Li D, King DP, Sun P, Bai X, Cao W, Gubbins S, Chen Y, Xie B, Guo J, Yin H, Liu Z: In-vitro and in-vivo phenotype of Asia1 foot-and-mouth disease viruses utilizing two non-RGD receptor recognition sites. BMC Microbiol 2011, 11: 1-12. 10.1186/1471-2180-11-1CrossRef
58.
go back to reference Gutierrez-Rivas M, Pulido MR, Baranowski E, Sobrino F, Saiz M: Tolerance to mutations in the foot-and-mouth disease virus integrin-binding RGD region is different in cultured cells and in vivo and depends on the capsid sequence context. J Gen Virol 2008, 89: 2531-2539. 10.1099/vir.0.2008/003194-0PubMedCrossRef Gutierrez-Rivas M, Pulido MR, Baranowski E, Sobrino F, Saiz M: Tolerance to mutations in the foot-and-mouth disease virus integrin-binding RGD region is different in cultured cells and in vivo and depends on the capsid sequence context. J Gen Virol 2008, 89: 2531-2539. 10.1099/vir.0.2008/003194-0PubMedCrossRef
59.
go back to reference Rieder E, Henry T, Duque H, Baxt B: Analysis of a foot-and-mouth disease virus type A24 isolate containing an SGD receptor recognition site in vitro and its pathogenesis in cattle. J Virol 2005, 79: 12989-12998. 10.1128/JVI.79.20.12989-12998.2005PubMedPubMedCentralCrossRef Rieder E, Henry T, Duque H, Baxt B: Analysis of a foot-and-mouth disease virus type A24 isolate containing an SGD receptor recognition site in vitro and its pathogenesis in cattle. J Virol 2005, 79: 12989-12998. 10.1128/JVI.79.20.12989-12998.2005PubMedPubMedCentralCrossRef
60.
go back to reference Rieder E, Bunch T, Brown F, Mason PW: Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice. J Virol 1993, 67: 5139-5145.PubMedPubMedCentral Rieder E, Bunch T, Brown F, Mason PW: Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice. J Virol 1993, 67: 5139-5145.PubMedPubMedCentral
61.
go back to reference Fry EE, Newman JW, Curry S, Najjam S, Jackson T, Blakemore W, Lea SM, Miller L, Burman A, King AM, Stuart DI: Structure of Foot-and-mouth disease virus serotype A10 61 alone and complexed with oligosaccharide receptor: receptor conservation in the face of antigenic variation. J Gen Virol 2005, 86: 1909-1920. 10.1099/vir.0.80730-0PubMedCrossRef Fry EE, Newman JW, Curry S, Najjam S, Jackson T, Blakemore W, Lea SM, Miller L, Burman A, King AM, Stuart DI: Structure of Foot-and-mouth disease virus serotype A10 61 alone and complexed with oligosaccharide receptor: receptor conservation in the face of antigenic variation. J Gen Virol 2005, 86: 1909-1920. 10.1099/vir.0.80730-0PubMedCrossRef
62.
go back to reference Guex N, Peitsch MC: SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997, 18: 2714-2723. 10.1002/elps.1150181505PubMedCrossRef Guex N, Peitsch MC: SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997, 18: 2714-2723. 10.1002/elps.1150181505PubMedCrossRef
63.
go back to reference Kaplan W, Littlejohn TG: Swiss-PDB Viewer (Deep View). Brief Bioinform 2001, 2: 195-197. 10.1093/bib/2.2.195PubMedCrossRef Kaplan W, Littlejohn TG: Swiss-PDB Viewer (Deep View). Brief Bioinform 2001, 2: 195-197. 10.1093/bib/2.2.195PubMedCrossRef
Metadata
Title
Examination of soluble integrin resistant mutants of foot-and-mouth disease virus
Authors
Paul Lawrence
Michael LaRocco
Barry Baxt
Elizabeth Rieder
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2013
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-10-2

Other articles of this Issue 1/2013

Virology Journal 1/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.